VF Brands: Global Supply Chain Strategy

Gary P. Pisano; Pamela  Adams

Case | HBS Case Collection | November 2009

VF Brands: Global Supply Chain Strategy

Abstract

This case examines VF Brands global supply chain strategy. Historically, VF has used a combination of in-house manufacturing and traditional arms-length sourcing arrangements. At the time of the case, the company is considering a third approach to supplier relations that involves much closer cooperation and partnerships. The goal of this "third way" approach is to create a sourcing relationship that combines some of the virtues of vertical integration with the flexibility of sourcing. Such arrangements are increasingly discussed in the operations literature and in practice. This case provides students an opportunity to do an in-depth analysis of such an arrangement and develop an understanding of the trade-offs involved.

Keywords: Global Strategy; Logistics; Supply Chain Management; Partners and Partnerships; Cooperation; Vertical Integration; Apparel and Accessories Industry;

Format: Print

16 pages

Educators Purchase

Citation:

Pisano, Gary P., and Pamela Adams. "VF Brands: Global Supply Chain Strategy." Harvard Business School Case 610-022, November 2009.

Manufacturing accounts for more than three-quarters of U.S. corporate patents. The competitive shock to this sector emanating from China's economic ascent could in theory either augment or stifle U.S. innovation. Using three decades of U.S. patents matched to corporate owners, we quantify how foreign competition affects domestic innovation. Rising import exposure intensifies competitive pressure, reducing sales, profitability, and R&D expenditure at U.S. firms. Accounting for confounding sectoral patenting trends, we find that U.S. patent production declines in sectors facing greater import competition. This adverse effect is larger among initially less profitable and less capital-intensive firms.

The ultimate solutions to the Covid-19 crisis may be big breakthroughs in building massive test and trace capacity and developing vaccines and drug remedies. But in the meantime, we should not ignore the potential cumulative impact of the many small things we already know how to do or might try that together could make a big dent in the current crisis. Big problems typically get tackled through a series of small solutions, each of which on its own may not seem particularly important but that together can have a huge impact. Creating and implementing a “small steps” strategy, however, will require strong leadership.

For more than two decades, scientific advances have been driving profound changes in drug discovery and the drug industry itself. This case provides an overview and description of these technical and scientific advances. Written for the nonscientific reader, it may be used as companion reading for other case materials that require basic knowledge of the tools, techniques, and approaches used in the pharmaceutical and biotechnology industries.

Faculty & Research

VF Brands: Global Supply Chain Strategy

Abstract

Citation:

About the Author

More from the Author

Faculty & Research

VF Brands: Global Supply Chain Strategy

Abstract

Citation:

Related Work

About the Author

More from the Author